DexCom, Inc.: Dexcom rtCGM is Likely to be Cost-Saving, Study Suggests
For people with diabetes treated with insulin, Dexcom rtCGM is associated with significant improvements over patients' lifetimes and is likely to be cost-saving to the NHS DexCom, Inc. (NASDAQ:DXCM)
United Kingdom San Diego United States Ben Byrne Dexcom Inc Association Of Continuous Glucose Monitoring With Glycemic
Source: finanznachrichten.de